This titrate-up and taper-down controversy stems from concerns regarding the potential for hyperglycemia upon initiation of total parenteral nutrition (TPN) and for hypoglycemia upon discontinuation.

Removing manganese from total parenteral nutrition may reverse neurologic deficits, so the investigators recommend assessing manganese levels in patients with neurologic or psychiatric disorders.